Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$15.03 - $16.32 $2,014 - $2,186
-134 Closed
0 $0
Q1 2023

May 15, 2023

SELL
$15.28 - $16.48 $4,324 - $4,663
-283 Reduced 67.87%
134 $2,000
Q4 2022

Feb 09, 2023

SELL
$12.42 - $15.62 $4,632 - $5,826
-373 Reduced 47.22%
417 $7,000
Q3 2022

Nov 14, 2022

SELL
$12.8 - $28.65 $2,432 - $5,443
-190 Reduced 19.39%
790 $10,000
Q2 2022

Aug 09, 2022

SELL
$13.12 - $15.03 $8,213 - $9,408
-626 Reduced 38.98%
980 $14,000
Q1 2022

May 16, 2022

SELL
$13.54 - $15.35 $5,808 - $6,585
-429 Reduced 21.08%
1,606 $23,000
Q4 2021

Feb 11, 2022

SELL
$13.17 - $16.4 $9,139 - $11,381
-694 Reduced 25.43%
2,035 $28,000
Q3 2021

Nov 12, 2021

BUY
$16.3 - $17.26 $4,922 - $5,212
302 Added 12.44%
2,729 $49,000
Q2 2021

Aug 16, 2021

SELL
$16.55 - $18.64 $13,041 - $14,688
-788 Reduced 24.51%
2,427 $41,000
Q4 2020

Feb 10, 2021

BUY
$15.39 - $18.97 $7,479 - $9,219
486 Added 17.81%
3,215 $59,000
Q3 2020

Nov 13, 2020

SELL
$17.1 - $19.19 $2,000 - $2,245
-117 Reduced 4.11%
2,729 $49,000
Q2 2020

Aug 14, 2020

SELL
$14.59 - $19.5 $11,438 - $15,288
-784 Reduced 21.6%
2,846 $51,000
Q1 2020

May 13, 2020

SELL
$13.02 - $20.31 $6,692 - $10,439
-514 Reduced 12.4%
3,630 $55,000
Q4 2019

Feb 07, 2020

BUY
$16.88 - $20.83 $4,709 - $5,811
279 Added 7.22%
4,144 $82,000
Q3 2019

Nov 07, 2019

BUY
$16.15 - $17.99 $2,341 - $2,608
145 Added 3.9%
3,865 $66,000
Q2 2019

Aug 13, 2019

BUY
$16.58 - $20.49 $16,298 - $20,141
983 Added 35.92%
3,720 $66,000
Q1 2019

May 15, 2019

BUY
$16.7 - $21.52 $718 - $925
43 Added 1.6%
2,737 $56,000
Q4 2018

Feb 13, 2019

BUY
$15.64 - $21.1 $42,134 - $56,843
2,694 New
2,694 $45,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $42.2B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Td Ameritrade Investment Management, LLC Portfolio

Follow Td Ameritrade Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Ameritrade Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Ameritrade Investment Management, LLC with notifications on news.